Objective-Perivascular cells, including pericytes, macrophages, smooth muscle cells, and other specialized cell types, like podocytes, participate in various aspects of vascular function. However, aside from the well-established roles of smooth muscle cells and pericytes, the contributions of other vascular-associated cells are poorly understood. Our goal was to ascertain the function of perivascular macrophages in adult tissues under nonpathological conditions. Approach and Results-We combined confocal microscopy, in vivo cell depletion, and in vitro assays to investigate the contribution of perivascular macrophages to vascular function. We found that resident perivascular macrophages are associated with capillaries at a frequency similar to that of pericytes. Macrophage depletion using either clodronate liposomes or antibodies unexpectedly resulted in hyperpermeability. This effect could be rescued when M2-like macrophages, but not M1-like macrophages or dendritic cells, were reconstituted in vivo, suggesting subtype-specific roles for macrophages in the regulation of vascular permeability. Furthermore, we found that permeability-promoting agents elicit motility and eventual dissociation of macrophages from the vasculature. Finally, in vitro assays showed that M2-like macrophages attenuate the phosphorylation of VE-cadherin upon exposure to permeability-promoting agents.
M acrophages are versatile cells that function as scavengers to eliminate cellular debris and contribute to the innate immune response. Some macrophages are short-lived, particularly those recruited during inflammation. In contrast, resident macrophages are long-lived, specialized cells that are part of almost every tissue and represent a phenotype wired for repair. 1, 2 Importantly, macrophages also exist in different activation states, whose extremes are referred to as M1 and M2 in analogy to Th1 and Th2 T cells. 2 
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The cross talk between macrophages and the vasculature has been significantly explored in the context of cancer. [3] [4] [5] Perivascular M2-like macrophages play a crucial role in tumor angiogenesis, and depletion of these cells significantly interferes with neovascularization, tumor growth, and cancer progression. [6] [7] [8] [9] In general, M2-like macrophages are considered to be proangiogenic, whereas M1-like macrophages may be angiostatic. 5 Using in vitro Matrigel angiogenesis assays, it has been shown that M2-like macrophages, and not M1-like macrophages, promote endothelial tube formation and colocalize with endothelial branch points. 10 These findings are consistent with the notion that during development, macrophages coordinate fusion of adjacent vascular sprouts, as they facilitate the bridging between filopodia and aid in vascular anastomosis. 11, 12 Together, these functions portray macrophages as important regulators of angiogenesis.
Although well accepted, the M1 to M2 paradigm is probably oversimplified. There most likely exist a spectrum of macrophage phenotypes in between the well-characterized M1 to M2 poles. Heterogeneous mixtures of macrophages with diverse phenotypes populate specific microenvironments, and the makeup of these populations is highly dependent on local cytokines. 13 In fact, recent macrophage transcriptome analyses revealed functional polarization of macrophages based on tissue-specific influences. [14] [15] [16] [17] These reports demonstrate the importance of environmental cues for functional polarization of macrophages. Moreover, macrophages have been described as controllers of tissue homeostasis that can sense and respond to environmental factors and perform accordingly. 18 From previous work, we have shown that endothelial cells (ECs) provide a specific niche for the differentiation of macrophages in culture and that contact with the endothelium favors M2-polarization. 19 Even in the absence of vascular pathology in vivo, monocytes/macrophages have been shown to patrol the inner surface of the endothelial wall and, in some cases, associate externally with capillaries. 20 These observations beg the question of the role of these perivascular macrophages under homeostatic conditions. Perivascular cells are known to play roles in capillary stability, protection against antiangiogenic drugs, and vascular constriction. 21 Pericytes are the prototypical and best studied perivascular cell type although smooth muscle cells, macrophages, and other tissue-specific cells such as podocytes and microglia are also included in this category. Their overlapping and distinctive functions, as well as tissue-specific contributions, are poorly understood.
In the current study, we sought to investigate the biological relevance of perivascular macrophages under homeostatic conditions. Real-time visualization of macrophage-endothelial interactions, as well as depletion and reconstitution of macrophages in vivo, revealed an unpredicted role for macrophages in the regulation of vascular barrier function.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Frequent Association of Macrophages With Blood Vessels Under Nonpathological Conditions
Macrophages are common residents of tissues and can be found in the vicinity of most blood vessels. To better characterize the association between resident macrophages and small-caliber vessels, we examined the distribution of macrophages on mesenteric vessels by confocal microscopy. We selected the mesentery because of its accessibility and relative transparency. From 3-dimensional reconstruction of z-stack confocal images, we noted that macrophages were frequently associated with mesenteric vessels ( Figure 1A ; Figure IA and IB in the online-only Data Supplement). These macrophages were often located on the abluminal side of blood vessels but were also found juxtaposed to the lumen and actively crossing the endothelial wall ( Figure IC in the online-only Data Supplement). Using macrophage and myeloid-specific markers (F4/80 and Mac1), we identified the population of perivascular macrophages located on the abluminal aspect of microvessels. This population comprised ≈20% of all cells in the mesentery ( Figure 1B through 1E ). The majority of these macrophages by flow cytometric analysis expressed the M2-like macrophage marker, Mrc1 (or CD206; Figures ID and IIA and IIB in the online-only Data Supplement). To be noted, the morphology and location of these macrophages were distinct from those of pericytes ( Figure 1F and 1G) or smooth muscle cells ( Figure IIC in the online-only Data Supplement). By intravital microscopy, we confirmed that this population of perivascular macrophages (Mrc1 + cells) was also present in vessels of the dermis ( Figure ID in the online-only Data Supplement, white arrowheads). Importantly, perivascular macrophages were morphologically elongated and characterized by Mrc1 high Mac1 low , in contrast to Mac1 high macrophages that were rounded and more broadly distributed in the tissue ( Figure 1H ; Figure IID in the online-only Data Supplement). These imaging experiments revealed that under nonpathological conditions, there was a direct and frequent association between macrophages and blood vessels. Furthermore, these perivascular macrophages expressed markers that indicated M2-polarity.
Resident Macrophages Contribute to the Regulation of the Endothelial Barrier
We next explored the biological relevance of the association between macrophages and blood vessels by removing macrophages in vivo and subsequently evaluating the effect of macrophage removal on vascular function in real time. Macrophages were depleted from the ear by intradermal clodronate liposome injection (Figure 2A ), whereas the contralateral ear was injected with control (PBS-loaded) liposomes. Clodronate liposome treatment resulted in a 70% reduction of macrophages by flow cytometric analysis ( Figure 2B ). The marked depletion of macrophages was not associated with any obvious structural abnormalities in blood vessels, but caused a significant decrease in barrier integrity and a hyperpermeable vascular response in the absence of any permeability mediator ( Figure 2C and 2E). These findings indicate that at baseline perivascular macrophages contribute to suppress permeability. To further examine whether these effects were in fact because of barrier dysfunction, we applied VEGFA (Vascular Endothelial Growth Factor A), a strong vascular permeability enhancer. Intravital imaging was initiated 5 minutes after VEGFA application and recorded for 20 minutes. Macrophage-depleted vasculature exhibited a striking elevation in vascular leakage on VEGFA exposure, whereas the control group showed only a modest increase in permeability by comparison ( Figure 2D and 2F). Note that the vascular dilatation induced by VEGFA in both the control group and the clodronate-treated group was equivalent ( Figure 2D ). In fact, vascular diameter increased by 1.254% (±0.04%) in control and by 1.242% (±0.036%) on clodronate treatment in equivalent-sized vessels (n=6, data not shown), indicating that the vasodilation response was unaffected, but barrier integrity was compromised.
To verify that the macrophage-mediated permeability was not solely dependent on VEGFA, we tested another permeability factor, bradykinin. On bradykinin addition, macrophage-depleted vessels also displayed a greater increase in permeability compared with vehicle-exposed vessels although the change was less drastic than that induced by VEGFA exposure ( Figure IIIA and IIIB in the online-only Data Supplement). This was not surprising because VEGF is
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ECs endothelial cells iBMMs immortalized bone marrow macrophages the most potent inducer of vascular permeability and reported to be 50 000 × more potent than histamine or bradykinin. 22, 23 Importantly, exposure to clodronate did not have an effect on the viability of ECs, pericytes, or smooth muscle ( Figure IIIC in the online-only Data Supplement). Next, we tested vascular permeability in op/op mice, which are deficient in Csf1-derived macrophages. The bone marrow resident macrophage populations in control versus op/ op homozygous mice were characterized via flow cytometry to reveal a significant reduction in F4/80-positive cells in the total CD45 + population ( Figure IIID in the online-only Data Supplement). Confocal imaging demonstrated an absence of Mac1-stained macrophages in the mesentery and a disordered vascular architecture ( Figure 2G ). Baseline peritoneal permeability after intravenous fluorescein isothiocyanate-ovalbumin injection was higher in the op/op mice than in the controls ( Figure 2H ). This result provides further evidence that macrophages participate in regulating vascular permeability in vivo.
Reconstitution of Macrophages in the Peritoneum Rescues Vascular Permeability
To determine whether macrophages were primarily responsible for the changes in vascular permeability, we considered a rescue approach. Macrophages were depleted from the peritoneum by intraperitoneal injection of clodronate liposomes following the protocol shown in Figure 3A . Flow cytometric analysis confirmed a major reduction of macrophages in the peritoneal cavity ( Figure 3B ). Subsequently, we evaluated the effect of macrophage depletion on peritoneal permeability and detected a faster and greater vascular leakage compared with control ( Figure 3C ). To determine whether macrophages contributed to the observed differences in permeability, unpolarized macrophages derived from bone marrow were reintroduced via intravenous injection 2 days before measuring peritoneal permeability. A significant reduction of permeability (58%) was detected on the reconstitution of macrophages ( Figure 3D ). This indicates that in fact macrophages play an essential role in the regulation of vascular permeability.
Effect of Different Subtypes of Macrophages on Vascular Permeability
Although clodronate liposomes have been extensively used to deplete macrophages, we could only eliminate 70% of the population. Thus, we explored an alternative approach to eliminate macrophages and further expand our initial findings. Specifically, we used an antibody against CSF1R, 24 which exclusively blocks the CSF1 pathway necessary for macrophage survival ( Figure 4A ). After treatment with the antibody, peritoneal macrophages were reduced by ≈90%, a higher percentage than the clodronate effect ( Figure 4B through 4D) . Importantly, the antibody did not appear to have deleterious disruption in blood vessels ( Figure 4C ). Furthermore, the antibody did not affect barrier function in vitro (transendothelial resistance), or induced an inflammatory response in the endothelium alone ( Figure IVA and IVB in the online-only Data Supplement).
After determining clearance of the antibody from the mouse circulation (by ELISA), we tested whether intravenousinjected macrophages could extravasate into the mesentery. To trace the injected cells, we used mCherry-labeled immortalized bone marrow macrophages (iBMMs, characterized in Figure  VA and VB in the online-only Data Supplement) for quantifying extravasated peritoneal macrophages. Sixteen hours after intravenous injection, 37% mCherry-positive cells were detected in the peritoneal cavity, indicating the significant homing potential of macrophages to that site ( Figure 4E and 4F) .
To determine the role of different subtypes of macrophages in the control of permeability, we injected polarized M1-like iBMMs, M2-like iBMMs, or bone marrow-derived dendritic cells into macrophage-depleted animals. A detailed characterization of iBMMs before and after polarization of M1 and M2 is provided in Figure VC and VD in the onlineonly Data Supplement. Determination of peritoneal permeability showed that only M2-like macrophages rescued the vascular permeability, which points to the specific role of M2-like macrophages in the protection from vascular permeability ( Figure 4G ). 
Macrophage Motility Is Increased on Induction of Vascular Permeability
During intravital imaging, we observed an obvious increase in macrophage motility when permeability was induced ( Figure 5A ). We considered that this might be an important component of the permeability response. To verify and quantify this observation, we tracked macrophage motility at an individual cell level and the combined change in macrophage motility in a field of view over time when tissues were exposed to VEGFA or vehicle control. Individual macrophages ( Figure 5B and 5D ) were analyzed with a motility program as described in the Materials and Methods in the online-only Data Supplement. Briefly, the difference in pixel location between distinct time frames was determined by changes in area occupied by the cell and normalized to the average of the total area. The approach revealed pixels that were different between 2 consecutive frames and could be visualized by different colors. In this manner, we obtained a compressed readout of all the locations occupied by the cell within a window of time ( Figure 5C and 5E, top) . In addition, cell motility was graphed every 2 minutes and shown as a single image ( Figure 5C and 5E, bottom). Using this approach, the motility and actual migration of macrophages on VEGFA treatment was evident, whereas movement was barely detectable in the absence of VEGFA. To exclude the possibility of any arbitrary bias and to gain a greater perspective on macrophage motility overall, we also evaluated all perivascular macrophages located in a given frame (60-150 cells) in a 20-minute interval. Ten frames were evaluated across several different animals per group (with VEGFA, n=4 or without VEGFA treatment, n=3; Figure 5F ). The data clearly demonstrate a strong positive correlation between vascular permeability and macrophage motility.
Macrophage's Binding to ECs Decreases on Induction of Vascular Permeability
To investigate whether different subtypes of macrophages would have different effects on vascular permeability, we first examined their affinity to ECs in vitro. Surprisingly, M1-like macrophages exhibited much less binding to ECs when compared with M2-like macrophages ( Figure 6A and 6B) . From intravital imaging analysis ( Figure 5A ), we were able to capture macrophages detaching from a vessel after administration of VEGFA. However, detachment events were not frequent in the 20-minute intravital imaging time window. Therefore, we resorted to in vitro culture experiments to evaluate macrophage dissociation on permeability induction in a longer time frame. We treated macrophages (M1-like or M2-like) and mouse ECs cocultures with the permeability factor, VEGFA, and observed dissociation of macrophages, particularly M2-like, on treatment ( Figure 6C ). To confirm this finding in vivo, we treated animals with adenovirus-expressing VEGFA and examined macrophage localization compared with animals injected with control adenoviral particles. We observed a similar detachment effect-not only did macrophages lose association with vessels ( Figure 6D ; Figure VIA in the online-only Data Supplement), but the total area covered by macrophages relative to vessels was also reduced ( Figure VIB in the online-only Data Supplement). Interestingly, the macrophages showed changes in morphology as well ( Figure 6D ). Quantification of macrophage dissociation from vessels was performed by flow cytometry on peritoneal lavage for F4/80 and Mrc1 double-positive cells after a single injection (1 μg of VEGFA intravenous; or vehicle control). We found that it took ≈60 minutes to notice a significant detachment of macrophages from vessels ( Figure 6E ).
Phosphorylation of VE-Cadherin Regulates Macrophage-Mediated Permeability
To gain insight into the molecular mechanism underlying the effect of M1-like versus M2-like macrophages on endothelial barrier function, we used in vitro electric cell-substrate impedance sensing to measure the current conduction across a cellular layer. A confluent monolayer of immortalized ECs were plated on an electrode-embedded plate. Macrophages (iBMMs) were then introduced to the culture. When M2-polarized iBMMs were added to the endothelial monolayer, the monolayer maintained resistance; however, the addition of M1-polarized iBMMs reduced the resistance, suggesting an induction of endothelial permeability ( Figure 6F and 6G). When permeability factors, like VEGF and thrombin, were added to this system, respectively, only M2-like macrophages were able to rescue the permeability induced by both mediators ( Figure 6H ). Intriguingly, we noticed that macrophages tend to have more filopodia and bridge adjacent ECs when the permeability factor was added ( Figure 6I) . In addition, the localization of β-catenin was redistributed from the cell membrane to the cytosol ( Figure 6I ). This finding led us to speculate that cell adhesion molecules located upstream of the β-catenin pathway might play a role in macrophage-mediated regulation of endothelial permeability. In fact, Western blots showed that ECs cocultured with M2-like macrophages expressed less phosphorylated VE-cadherin when compared with ECs cocultured with M1-like macrophages or cultured alone ( Figure 6J and 6K) . These findings indicate that M2-like macrophages control the endothelial barrier, at least in part, through regulating VE-cadherin phosphorylation in ECs.
Discussion
Perivascular cells, such as smooth muscle and pericytes, tightly associate with the endothelial wall and provide structural support and contractility to vessels. This well-established function contrasts the poorly understood role of perivascular macrophages. Here, we sought to address the biological relevance of endothelial-macrophage interactions under homeostatic conditions. Stable associations of M2-like macrophages with vessels were identified at high frequency in both mesentery and dermis. Using real-time microscopy, we found that removal of macrophages conveyed a hyperpermeable response to the endothelium on challenge, through a process that required increased macrophage motility and dissociation from the vascular wall. Importantly, reconstitution of M2-like macrophages, but not of M1-like macrophages or dendritic cells, rescued a compromised vascular barrier in macrophage-depleted tissues. To be noted, different subtypes of macrophages affiliate and contribute to the endothelial barrier in different ways. The findings point to a significant role of macrophages in mediating the homeostasis of vascular permeability.
The maintenance of vascular barrier function has been extensively studied, albeit the majority of such studies have focused on either transcellular or intercellular pathways. The contribution of heterotypic cell interactions in vascular barrier has only recently gained credence after a preponderance of evidence that pericytes are essential contributors to barrier integrity, particularly in the brain. The most direct proof came from studies using a variety of platelet-derived growth factor signaling deficient mice that have significantly decreased number of pericytes. Reduction of pericyte coverage in the brain (Pdgfb +/− , Pdgfb-F7) resulted in blood-brain barrier breakdown and accumulation of plasma-derived proteins, ultimately leading to learning and memory deficiencies. 25 Using a slightly different model (Pdgfb ret/ret mice), Armulik et al 26 the blood-brain barrier and pericyte loss, concluding that pericyte number determines the relative leakiness of vessels in the central nervous system during development. 27 Mechanistically, these studies and others have indicated that heterotypic interactions between ECs and pericytes are essential for the development of mature tight junctions between ECs, at least in the brain. 27, 28 Our findings indicate that interactions of a subset of macrophages with vessels also contribute to the maintenance of endothelial barrier. Moreover, we have demonstrated both in vitro and in vivo that M2-like macrophages contribute to the protection of endothelial barrier, whereas M1-like macrophages disrupt it. In addition, M1-like and M2-like macrophages tend to have different levels of affiliation with ECs in the absence of pathology. This indicates an interesting distinction between macrophage subtypes, and these differences are consistent with the functionally opposite roles of M1-like and M2-like macrophages in cancer and other pathological conditions. Interestingly, under pathological conditions, tumorassociated macrophages have been shown to promote, rather than to suppress vascular permeability. 29 Real-time imaging of a mouse mammary cancer model revealed synchronized tumor cell intravasation and localized blood vessel permeability with TIE2 hi macrophages mediating the permeability via VEGFA destabilization of EC junctions. 30 These findings are in direct discordance with our results. However, we speculate that M2-tumor-associated macrophages might be functionally distinct from the M2-like resident macrophages that we studied under homeostatic conditions. An important consideration could also be the embryonic origin of each subset, as recently bone marrow and yolk sac origins have been attributed to distinct populations of macrophages. 31 A comprehensive transcriptional profile, rather than a handful of markers, would clarify this point. Notwithstanding, information from recent human trials might have already offered important insights. Clinical trials conducted by Roche using CSF1R monoclonal antibody (RG7155) therapy were successful in depleting tumor-associated macrophages from the tumor tissue. 24, 32 Importantly, targeting tumor-associated macrophages via the CSF1/CSF1R axis was efficacious and resulted in improvement of patients. However, several side effects were noted, with facial edema being the most common. 33, 34 Because delivery of CSF1R inhibitor was applied via intravenous infusion, edema was likely caused by the systemic depletion of macrophages and in areas away from the tumor (ie, face). These findings support the concept put forward by the present study that perivascular macrophages in the dermis offer stability to vascular networks by enhancing barrier function in sites that are disease free.
In this study, the effects on vascular permeability were more clearly detected on challenge with an agonist, perhaps because our depletion was short lived. We used two common permeability agents, VEGF and bradykinin, and inquired as to the potential role of macrophages in each setting. These molecules change permeability through distinct mechanisms and also vary in the time of induced endothelial response. VEGF targets receptors located on the abluminal side of endothelium, whereas bradykinin works through the luminal side. Because of differences in these two permeability mediators, one could expect a distinct protective response by macrophages. It is interesting, however, that in both cases, permeability was augmented by the depletion of macrophages from the tissue.
Furthermore, we noted that application of permeability mediators promoted movement of macrophages on vessels with progressive detachment. Vessel-associated macrophage movement has only been reported in a handful of cases. Al-Roubaie et al 35 claimed that most macrophages are stationary, which is in line with our observations. Gray et al 36 demonstrated that macrophages in contact with the endothelium migrated faster than the ones in the tissue. Interestingly, we noticed that on long-term exposure to permeability factors, macrophages exhibited higher motility, consistent with the fact that macrophages express receptors for these mediators. This may offer a possible mechanism of how macrophages dynamically regulate permeability. Nonetheless, whether such motility is the cause or the consequence of vascular leakage is still unknown. In fact, the present study did not delve into the mechanism by which macrophages limit vascular permeability. Additional investigations will be necessary to depict the array of heterotypic interactions between endothelialmacrophages and identify cell surface and secreted molecules involved in the regulation of barrier function. Also, questions related to the molecular toolkit that enables some macrophages to navigate and interact with the vasculature are pending. Additional efforts are also needed to clarify the nature of the multiple heterotypic interactions between different subsets of macrophages and the endothelium in vivo. Nonetheless, the findings presented here offer novel information on the functional nature of endothelia-macrophage heterotypic interactions in the context of vascular homeostasis.
